GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (GREY:BBAGF) » Definitions » E10

BB Biotech AG (BB Biotech AG) E10 : $8.74 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is BB Biotech AG E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

BB Biotech AG's adjusted earnings per share data for the three months ended in Dec. 2023 was $2.301. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $8.74 for the trailing ten years ended in Dec. 2023.

During the past 12 months, BB Biotech AG's average E10 Growth Rate was -1.30% per year. During the past 3 years, the average E10 Growth Rate was -1.60% per year. During the past 5 years, the average E10 Growth Rate was 4.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of BB Biotech AG was 11.40% per year. The lowest was -1.60% per year. And the median was 3.75% per year.

As of today (2024-05-15), BB Biotech AG's current stock price is $76.05789. BB Biotech AG's E10 for the quarter that ended in Dec. 2023 was $8.74. BB Biotech AG's Shiller PE Ratio of today is 8.70.

During the past 13 years, the highest Shiller PE Ratio of BB Biotech AG was 9.01. The lowest was 5.32. And the median was 7.27.


BB Biotech AG E10 Historical Data

The historical data trend for BB Biotech AG's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG E10 Chart

BB Biotech AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.99 7.57 12.64 8.86 8.74

BB Biotech AG Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Dec17 Dec18 Dec19 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.86 8.82 8.78 8.57 8.74

Competitive Comparison of BB Biotech AG's E10

For the Biotechnology subindustry, BB Biotech AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BB Biotech AG's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's Shiller PE Ratio falls into.



BB Biotech AG E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BB Biotech AG's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.301/106.4611*106.4611
=2.301

Current CPI (Dec. 2023) = 106.4611.

BB Biotech AG Quarterly Data

per share eps CPI Adj_EPS
201106 -1.101 102.678 -1.142
201109 -1.614 101.811 -1.688
201112 1.566 101.408 1.644
201203 3.391 101.826 3.545
201206 2.268 101.596 2.377
201209 2.145 101.392 2.252
201212 -2.392 100.968 -2.522
201303 6.687 101.221 7.033
201306 2.443 101.466 2.563
201309 6.478 101.336 6.806
201312 1.975 101.036 2.081
201403 1.311 101.224 1.379
201406 3.847 101.517 4.034
201409 9.104 101.247 9.573
201412 13.161 100.704 13.913
201503 6.889 100.339 7.309
201506 6.437 100.464 6.821
201509 -10.612 99.785 -11.322
201512 9.195 99.386 9.850
201603 -22.169 99.475 -23.726
201606 0.660 100.088 0.702
201609 7.367 99.604 7.874
201612 -0.441 99.380 -0.472
201703 6.760 100.040 7.194
201706 1.932 100.285 2.051
201712 12.584 100.213 13.369
201812 -8.579 100.906 -9.051
201912 12.447 101.063 13.112
202012 14.048 100.241 14.920
202103 4.291 100.800 4.532
202106 2.556 101.352 2.685
202112 -7.937 101.776 -8.302
202203 -5.842 103.205 -6.026
202206 -4.360 104.783 -4.430
202209 3.935 104.835 3.996
202212 -0.687 104.666 -0.699
202303 -5.003 106.245 -5.013
202306 -0.267 106.576 -0.267
202309 -0.989 106.570 -0.988
202312 2.301 106.461 2.301

Add all the adjusted EPS together and divide 10 will get our e10.


BB Biotech AG  (GREY:BBAGF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

BB Biotech AG's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=76.05789/8.74
=8.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of BB Biotech AG was 9.01. The lowest was 5.32. And the median was 7.27.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


BB Biotech AG E10 Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


BB Biotech AG (BB Biotech AG) Business Description

Traded in Other Exchanges
Address
Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.

BB Biotech AG (BB Biotech AG) Headlines

No Headlines